Mon Dec. 18th 2023
CyberKnife – ARO's newest treatment machine has officially turned one year old!. 12 months have passed since ARO treated thier first brain cancer patient with CyberKnife, setting the stage for a remarkable journey in the field of cancer treatment.
Wed Nov. 1st 2023
Study finds that after five years, 96% of the men who received five doses of the multi-beam radiotherapy were cancer-free, compared to 95% who received at least 20 doses of standard radiotherapy.
Mon Sept. 25th 2023
The ARO team had a strong presence at the 2023 New Zealand Institute of Medical Radiation Technology (NZIMRT) conference, held from September 15 - 17 in Queenstown. They gave four presentations covering a range of topics.
Mon Sept. 25th 2023
The team at ARO engaged in ‘Connect’, one of the Five Ways for Five Days of Mental Health Awareness Week. It refers to making social connections, or whakawhanaungatanga.
Tue Sept. 5th 2023
ARO's new CT scanner is the first of its' kind in Australasia. It uses the latest in AI technologies to provide outstanding image quality, allowing our medical professionals to locate the treatment area within a patient with a high level of precision.
Thu Aug. 24th 2023
Our expansion to the North Shore will bring the much-needed care closer to home for many patients, ensuring convenience and accessibility during their cancer journey.
Wed Aug. 23rd 2023
Dr Kate McLellan comes with 20 years of experience in various roles within the health sector both in New Zealand and the UK.
Tue Dec. 13th 2022
Introducing CyberKnife is about giving Kiwi access to world-leading treatment and minimising the impact of an already challenging time in people’s lives.
Thu Aug. 26th 2021
As an essential medical service, ARO is open. ARO’s aim is to ensure patients receive radiation therapy treatment within a safe environment.
Thu March 26th 2020
As an essential medical service, ARO would like to reassure patients and their support networks that ARO is open.
Mon Nov. 26th 2018
New Zealand's first private radiation oncology centre turns 10.
Tue Oct. 10th 2017
PSMA is an enzyme found in abundance on the cell surface of prostate cancer cells. Until recently patients newly diagnosed with high risk prostate cancer or patients where the prostate cancer has returned or metastasised would generally undergo a range of scans such as CT, bone and MRI to detect and stage prostate cancer.
